New Service: Alicanto for Antibody Discovery from Human Serum

Jul 14, 2023 | Products, Science

We recently had the pleasure of attending the PEGS Boston Conference. We had the privilege of showcasing our work through a poster presentation, a talk, and an exhibit booth. Among the highlights were engaging with experts, exchanging ideas, and strengthening our network within the community. But perhaps the most important was launching our newest service: Alicanto For Antibody Discovery From Human Serum. It was truly a great time for Abterra Biosciences!

Watch our CEO, Dr. Natalie Castellana’s presentation on Discovering SARS-CoV2 Antibodies From Patient Serum With Alicanto below. This was our first antibody discovery project utilizing human serum!

Click below to watch the presentation.

VHH Antibody Repertoire to Phage Library Comparison

We used Reptor to compare the VHH antibody repertoire from an immunized llama to a phage library constructed from the same source.

Case Study: Reptor Biological vs Technical Replicates

Replicates of immune repertoire sequencing projects can provide invaluable information about the total diversity of a sample.

Abterra Opens Its Doors To Celebrate New Location With Open House

Celebrating milestones is an important part of our personal and professional journeys. We wanted to commemorate this exciting new chapter in Abterra's story with the people who mean the most to us: our devoted employees, cherished families, esteemed investors, and...